BOND Ready-To-Use Primary Antibody CDX2 — Class II medical device recall Z-2481-2021
Terminated recall by Leica Microsystems, Inc., reported 2021-09-22, distributed nationwide. Product may not perform as specified in IFU.
| Recall number | Z-2481-2021 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Leica Microsystems, Inc., Buffalo Grove, IL, United States |
| Recall initiated | 2021-07-30 |
| Classified | 2021-09-16 |
| Reported by FDA | 2021-09-22 |
| Terminated | 2023-06-22 |
| Distributed | Nationwide (US) |
| Quantity | 237 units |
| Lot numbers | 69909 |
| Model numbers | PA0375 |
Product
BOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA0375
Reason for recall
Product may not perform as specified in IFU.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2481-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.